브루톤 티로신 키나제 억제제의 투여
본 발명은 상태, 예컨대 암 및 자가면역 질환을 치료하는 데 사용하기 위해 BTK 억제제, 즉 (S)-5-아미노-3-(4-((5-플루오로-2-메톡시벤즈아미도)메틸)페닐)-1-(1,1,1-트리플루오로프로판-2-일)-1H-피라졸-4-카르복스아미드 또는 그의 제약상 허용되는 염의 용량을 투여하는 방법을 제공한다. The present invention provides a method of administering doses of the BTK inhibitor, (S)-5-amino-3-(4-((5-fluoro-2-methoxybenza...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BRANDHUBER BARBARA JEAN KU NORA CHIEN YEE NANDA NISHA TSAI DONALD SMITH STEVEN AUGUST |
| description | 본 발명은 상태, 예컨대 암 및 자가면역 질환을 치료하는 데 사용하기 위해 BTK 억제제, 즉 (S)-5-아미노-3-(4-((5-플루오로-2-메톡시벤즈아미도)메틸)페닐)-1-(1,1,1-트리플루오로프로판-2-일)-1H-피라졸-4-카르복스아미드 또는 그의 제약상 허용되는 염의 용량을 투여하는 방법을 제공한다.
The present invention provides a method of administering doses of the BTK inhibitor, (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1H-pyrazole-4-carboxamide or a pharmaceutically acceptable salt thereof for use in treating conditions such as cancer and autoimmune diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20220100992A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20220100992A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20220100992A3</originalsourceid><addsrcrecordid>eNrjZDB8vaPn9eIVb9uWKLzt3vB64Zw33QsU3jYted00482COQpvpm0FUiA0d4bC2441b6av4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BRgZGRgaGBgaWlkaOxsSpAgCx2zqF</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>브루톤 티로신 키나제 억제제의 투여</title><source>esp@cenet</source><creator>BRANDHUBER BARBARA JEAN ; KU NORA CHIEN YEE ; NANDA NISHA ; TSAI DONALD ; SMITH STEVEN AUGUST</creator><creatorcontrib>BRANDHUBER BARBARA JEAN ; KU NORA CHIEN YEE ; NANDA NISHA ; TSAI DONALD ; SMITH STEVEN AUGUST</creatorcontrib><description>본 발명은 상태, 예컨대 암 및 자가면역 질환을 치료하는 데 사용하기 위해 BTK 억제제, 즉 (S)-5-아미노-3-(4-((5-플루오로-2-메톡시벤즈아미도)메틸)페닐)-1-(1,1,1-트리플루오로프로판-2-일)-1H-피라졸-4-카르복스아미드 또는 그의 제약상 허용되는 염의 용량을 투여하는 방법을 제공한다.
The present invention provides a method of administering doses of the BTK inhibitor, (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1H-pyrazole-4-carboxamide or a pharmaceutically acceptable salt thereof for use in treating conditions such as cancer and autoimmune diseases.</description><language>kor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220718&DB=EPODOC&CC=KR&NR=20220100992A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220718&DB=EPODOC&CC=KR&NR=20220100992A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BRANDHUBER BARBARA JEAN</creatorcontrib><creatorcontrib>KU NORA CHIEN YEE</creatorcontrib><creatorcontrib>NANDA NISHA</creatorcontrib><creatorcontrib>TSAI DONALD</creatorcontrib><creatorcontrib>SMITH STEVEN AUGUST</creatorcontrib><title>브루톤 티로신 키나제 억제제의 투여</title><description>본 발명은 상태, 예컨대 암 및 자가면역 질환을 치료하는 데 사용하기 위해 BTK 억제제, 즉 (S)-5-아미노-3-(4-((5-플루오로-2-메톡시벤즈아미도)메틸)페닐)-1-(1,1,1-트리플루오로프로판-2-일)-1H-피라졸-4-카르복스아미드 또는 그의 제약상 허용되는 염의 용량을 투여하는 방법을 제공한다.
The present invention provides a method of administering doses of the BTK inhibitor, (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1H-pyrazole-4-carboxamide or a pharmaceutically acceptable salt thereof for use in treating conditions such as cancer and autoimmune diseases.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB8vaPn9eIVb9uWKLzt3vB64Zw33QsU3jYted00482COQpvpm0FUiA0d4bC2441b6av4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BRgZGRgaGBgaWlkaOxsSpAgCx2zqF</recordid><startdate>20220718</startdate><enddate>20220718</enddate><creator>BRANDHUBER BARBARA JEAN</creator><creator>KU NORA CHIEN YEE</creator><creator>NANDA NISHA</creator><creator>TSAI DONALD</creator><creator>SMITH STEVEN AUGUST</creator><scope>EVB</scope></search><sort><creationdate>20220718</creationdate><title>브루톤 티로신 키나제 억제제의 투여</title><author>BRANDHUBER BARBARA JEAN ; KU NORA CHIEN YEE ; NANDA NISHA ; TSAI DONALD ; SMITH STEVEN AUGUST</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20220100992A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BRANDHUBER BARBARA JEAN</creatorcontrib><creatorcontrib>KU NORA CHIEN YEE</creatorcontrib><creatorcontrib>NANDA NISHA</creatorcontrib><creatorcontrib>TSAI DONALD</creatorcontrib><creatorcontrib>SMITH STEVEN AUGUST</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BRANDHUBER BARBARA JEAN</au><au>KU NORA CHIEN YEE</au><au>NANDA NISHA</au><au>TSAI DONALD</au><au>SMITH STEVEN AUGUST</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>브루톤 티로신 키나제 억제제의 투여</title><date>2022-07-18</date><risdate>2022</risdate><abstract>본 발명은 상태, 예컨대 암 및 자가면역 질환을 치료하는 데 사용하기 위해 BTK 억제제, 즉 (S)-5-아미노-3-(4-((5-플루오로-2-메톡시벤즈아미도)메틸)페닐)-1-(1,1,1-트리플루오로프로판-2-일)-1H-피라졸-4-카르복스아미드 또는 그의 제약상 허용되는 염의 용량을 투여하는 방법을 제공한다.
The present invention provides a method of administering doses of the BTK inhibitor, (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1H-pyrazole-4-carboxamide or a pharmaceutically acceptable salt thereof for use in treating conditions such as cancer and autoimmune diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | kor |
| recordid | cdi_epo_espacenet_KR20220100992A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 브루톤 티로신 키나제 억제제의 투여 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T22%3A41%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BRANDHUBER%20BARBARA%20JEAN&rft.date=2022-07-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20220100992A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |